Antidepressant Switching as a Proxy Phenotype for Drug Nonresponse: Investigating Clinical, Demographic, and Genetic Characteristics

Background: Selective serotonin reuptake inhibitors (SSRIs) are a first-line pharmacological therapy in major depressive disorder (MDD), but treatment response rates are low. Clinical trials lack the power to study the genetic contribution to SSRI response. Real-world evidence from electronic health...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chris Wai Hang Lo, Alexandra C. Gillett, Matthew H. Iveson, Michelle Kamp, Chiara Fabbri, Win Lee Edwin Wong, Dale Handley, Oliver Pain, Evangelos Vassos, Naomi R. Wray, Heather C. Whalley, Danyang Li, Allan H. Young, Andrew M. McIntosh, Cathryn M. Lewis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2025-07-01
Colecção:	Biological Psychiatry Global Open Science
Assuntos:	Antidepressant response Electronic health records Generation Scotland GWAS Selective serotonin reuptake inhibitors (SSRIs) UK Biobank
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2667174325000564
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!